已收盘 03-07 16:00:00 美东时间
0.000
0.00%
Century Therapeutics reported financial results for 2025 and highlighted progress in developing cell therapies for type 1 diabetes and cancer. The company expects to submit an IND for CNTY-813, a potential functional cure for type 1 diabetes, in Q4 2026, with initial clinical data anticipated in H2 2027. CNTY-308, targeting B-cell-mediated diseases, is on track to enter the clinic in 2026. Century strengthened its balance sheet with a $135 millio...
03-12 12:00
Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors Proceeds support the achievement of value inflection points for multiple RNA editing programs
03-09 19:36
Relmada Therapeutics, a biotechnology company, has secured approximately $160 million through a PIPE financing, with participation from leading investors. The transaction includes 29.47 million common shares and pre-funded warrants for 4.21 million shares. Proceeds will support working capital, general corporate purposes, and advancing R&D efforts. The financing is expected to close on March 11, 2026.
03-09 11:05
Crescent Biopharma Inc. has announced a private placement of approximately $185 million in securities to institutional and accredited investors. The offering, which is expected to close around Decembe...
2025-12-04 19:37
Tubulis, with latest funding, has raised 495 million euros Funds aim to expand trials of a lead cancer treatment product Market for targeted treatments may reach $31 billion by 2030 By Bhanvi Satija L...
2025-10-15 17:00
Newmark Appoints Justin Shepherd as Co-Head of U.S. Healthcare Capital Markets ...
2025-03-13 01:04
NEW YORK, NY, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASD...
2022-02-16 04:26
美国最大的社区社交平台Nextdoor计划借道SPAC上市,其PIPE投资者包括Ark Invest;加密货币运营商Circle宣布将与SPAC公司CND合并上市 >>
2021-07-09 16:49